Author
Rania Dayoub
Recent research
- Health & Medicine
Finerenone in Patients with Focal Segmental Glomerulosclerosis
Background: Mineralocorticoid receptor overactivation is implicated in podocyte injury and glomerulosclerosis. In a prespecified analysis of the FIND-CKD trial, we examined the efficacy and safety of finerenone in participants with focal segmental glomerulosclerosis (FSGS). Metho...